Current Environment: Production

Jeffrey Lo | Medical Services

Programs & Services

Languages

  • English

Jeffrey Lo | Education

Undergraduate School

Brown University

2007, Providence, RI

Medical School

University of Oklahoma College of Medicine

2014, Oklahoma City, OK

Internship

Pediatrics

Children's Mercy Hospital and Clinics

2014, Kansas City, MO

Residency

Pediatrics

Children's Mercy Hospital and Clinics

2017, Kansas City, MO

Fellowship

Sports Medicine

Boston Children's Hospital

2023, Boston, MA

Fellowship

Pediatric Rheumatology

Boston Children's Hospital

2021, Boston, MA

Jeffrey Lo | Certifications

  • American Board of Pediatrics (General)
  • American Board of Pediatrics (Sports Medicine)

Jeffrey Lo | Professional History

Dr. Lo is a medical sports medicine physician who completed training in both sports medicine and pediatric rheumatology. He enjoys providing comprehensive musculoskeletal care. He has special interests in caring for athletes with autoimmune diseases, hypermobility syndromes, and athletes with exertional leg pain.

Jeffrey Lo | Publications

  1. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. J Pediatr. 2021 05; 232:127-132.e3. View Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes. Abstract

  2. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. J Clin Invest. 2020 11 02; 130(11):5942-5950. View Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children. Abstract

  3. Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. JCI Insight. 2020 03 26; 5(6). View Th17 reprogramming of T cells in systemic juvenile idiopathic arthritis. Abstract

  4. An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation. J Inherit Metab Dis. 2020 07; 43(4):880-890. View An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation. Abstract

BESbswy
BESbswy